glp 1 and stomach paralysis GLP-1 Risk: Clinical Evidence & Safety – PlexusDx GLP-1 Intolerance and Endoscopic Sleeve

Once-daily oral GLP-1 therapy Helps control appetite and increase satiety Clinical trials indicate ~1215% weight loss Patient-centric advantages Can be taken anytime (no fasting required) No strict food restrictions Potential to improve long-term adherence Access & pricing (as reported) ~$149/month (starting dose, self-pay) Up to ~$349/month depending on dosage With insurance: ~$25$50/month Safety consideration Like other GLP-1 drugs, it carries warnings related to thyroid tumors and requires proper medical supervision

Adjuvant radiotherapy remains controversial

N Engl J Med 389:2221-32

Medicare does not cover Zepbound or any drug prescribed primarily for weight loss

Curr Drug Targets 5, 565571 (2004)

This discrepancy creates confusion and can lead to a denial if the requested medication is not indicated for the condition listed in the code